Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $278.96 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inspire Medical Systems, Inc. | $132.95 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $90.66 | 5 | $0 (2023) |
| Smith+Nephew, Inc. | $26.79 | 2 | $0 (2022) |
| Intersect ENT, Inc. | $14.77 | 1 | $0 (2021) |
| GENZYME CORPORATION | $13.79 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.79 | 1 | GENZYME CORPORATION ($13.79) |
| 2023 | $174.15 | 4 | Inspire Medical Systems, Inc. ($132.95) |
| 2022 | $44.62 | 3 | GlaxoSmithKline, LLC. ($29.59) |
| 2021 | $34.64 | 2 | GlaxoSmithKline, LLC. ($19.87) |
| 2019 | $11.76 | 1 | Smith+Nephew, Inc. ($11.76) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Immunology | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: IMMUNOLOGY | ||||||
| 08/10/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $115.99 | General |
| Category: NEUROLOGY | ||||||
| 01/28/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: NEUROLOGY | ||||||
| 12/21/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: IMMUNOLOGY | ||||||
| 07/28/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: IMMUNOLOGY | ||||||
| 03/23/2022 | Smith+Nephew, Inc. | Coblation (Device) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: ENT | ||||||
| 09/23/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2021 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/06/2019 | Smith+Nephew, Inc. | Coblation - Tonsil Wands (Device) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: ENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 811 | 877 | $192,543 | $64,381 |
| 2022 | 13 | 912 | 1,008 | $229,085 | $78,702 |
| 2021 | 14 | 895 | 1,007 | $220,000 | $71,982 |
| 2020 | 12 | 759 | 848 | $147,258 | $49,126 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 117 | 117 | $38,643 | $12,339 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 183 | 218 | $39,110 | $12,195 | 31.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 162 | 162 | $35,802 | $11,648 | 32.5% |
| 31525 | Diagnostic exam of voice box using an endoscope | Office | 2023 | 53 | 53 | $26,387 | $9,970 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 83 | $21,172 | $7,485 | 35.4% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 25 | 34 | $13,094 | $4,783 | 36.5% |
| 92511 | Exam of the nose and throat using an endoscope | Office | 2023 | 22 | 26 | $6,046 | $2,227 | 36.8% |
| 92504 | Exam of ear using a microscope | Office | 2023 | 70 | 76 | $4,408 | $1,303 | 29.6% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 40 | 41 | $3,124 | $874.65 | 28.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,998 | $762.87 | 38.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,581 | $445.52 | 28.2% |
| 92568 | Test to assess middle ear muscle reflex | Office | 2023 | 37 | 38 | $1,178 | $348.00 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 151 | 151 | $49,981 | $16,397 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 172 | 231 | $41,580 | $14,108 | 33.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 171 | 171 | $37,791 | $11,894 | 31.5% |
| 31525 | Diagnostic exam of voice box using an endoscope | Office | 2022 | 50 | 51 | $25,449 | $9,664 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 90 | $23,040 | $8,127 | 35.3% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 41 | 48 | $18,624 | $6,745 | 36.2% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2022 | 14 | 20 | $10,120 | $4,325 | 42.7% |
| 92504 | Exam of ear using a microscope | Office | 2022 | 103 | 111 | $6,438 | $2,250 | 34.9% |
| 31238 | Control of bleeding of nose using an endoscope | Office | 2022 | 11 | 11 | $5,456 | $1,883 | 34.5% |
| 92511 | Exam of the nose and throat using an endoscope | Office | 2022 | 16 | 16 | $3,696 | $1,397 | 37.8% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 40 | 42 | $3,226 | $893.91 | 27.7% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 26 | 26 | $2,444 | $636.99 | 26.1% |
| 92568 | Test to assess middle ear muscle reflex | Office | 2022 | 38 | 40 | $1,240 | $380.55 | 30.7% |
About Dr. Daniel Downs, MD
Dr. Daniel Downs, MD is a Otolaryngology healthcare provider based in Flagstaff, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831182831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Downs, MD has received a total of $278.96 in payments from pharmaceutical and medical device companies, with $13.79 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($278.96).
As a Medicare-enrolled provider, Downs has provided services to 3,377 Medicare beneficiaries, totaling 3,740 services with total Medicare billing of $264,192. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Flagstaff, AZ
- Active Since 08/24/2005
- Last Updated 07/14/2021
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1831182831
Products in Payments
- INSPIRE (Device) $132.95
- NUCALA (Biological) $90.66
- Coblation (Device) $15.03
- PROPEL (Device) $14.77
- DUPIXENT (Biological) $13.79
- Coblation - Tonsil Wands (Device) $11.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.